Long-term outcomes in five patients with autoimmune pulmonary alveolar proteinosis treated with molgramostim inhalation solution

Saved in:
Bibliographic Details
Main Authors: Celia Montaño, Elisabeth Bendstrup, Ida Rønnov-Jessen, Sara Salgado, Georg Sterniste, Arschang Valipour, Marcel Veltkamp, Maria Molina-Molina
Format: Article
Language:English
Published: European Respiratory Society 2025-01-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/11/1/00567-2024.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849704913398923264
author Celia Montaño
Elisabeth Bendstrup
Ida Rønnov-Jessen
Sara Salgado
Georg Sterniste
Arschang Valipour
Marcel Veltkamp
Maria Molina-Molina
author_facet Celia Montaño
Elisabeth Bendstrup
Ida Rønnov-Jessen
Sara Salgado
Georg Sterniste
Arschang Valipour
Marcel Veltkamp
Maria Molina-Molina
author_sort Celia Montaño
collection DOAJ
format Article
id doaj-art-ca30ab1ce3c5486292ff8d5037c0e280
institution DOAJ
issn 2312-0541
language English
publishDate 2025-01-01
publisher European Respiratory Society
record_format Article
series ERJ Open Research
spelling doaj-art-ca30ab1ce3c5486292ff8d5037c0e2802025-08-20T03:16:36ZengEuropean Respiratory SocietyERJ Open Research2312-05412025-01-0111110.1183/23120541.00567-202400567-2024Long-term outcomes in five patients with autoimmune pulmonary alveolar proteinosis treated with molgramostim inhalation solutionCelia Montaño0Elisabeth Bendstrup1Ida Rønnov-Jessen2Sara Salgado3Georg Sterniste4Arschang Valipour5Marcel Veltkamp6Maria Molina-Molina7 Interstitial Lung Diseases Unit, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), CIBERES, Barcelona, Spain Center for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital and Department of Clinical Medicine, Aarhus University, Aarhus, Denmark Center for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital and Department of Clinical Medicine, Aarhus University, Aarhus, Denmark Pulmonology Department, Interstitial Lung Diseases Unit, Pulido Valente Hospital, Lisbon, Portugal Department of Respiratory and Critical Care Medicine, Karl-Landsteiner-Institute for Lung Research, Vienna Health Care Group, Klinik Floridsdorf, Vienna, Austria Department of Respiratory and Critical Care Medicine, Karl-Landsteiner-Institute for Lung Research, Vienna Health Care Group, Klinik Floridsdorf, Vienna, Austria ILD Center of Excellence, Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands Interstitial Lung Diseases Unit, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), CIBERES, Barcelona, Spain http://openres.ersjournals.com/content/11/1/00567-2024.full
spellingShingle Celia Montaño
Elisabeth Bendstrup
Ida Rønnov-Jessen
Sara Salgado
Georg Sterniste
Arschang Valipour
Marcel Veltkamp
Maria Molina-Molina
Long-term outcomes in five patients with autoimmune pulmonary alveolar proteinosis treated with molgramostim inhalation solution
ERJ Open Research
title Long-term outcomes in five patients with autoimmune pulmonary alveolar proteinosis treated with molgramostim inhalation solution
title_full Long-term outcomes in five patients with autoimmune pulmonary alveolar proteinosis treated with molgramostim inhalation solution
title_fullStr Long-term outcomes in five patients with autoimmune pulmonary alveolar proteinosis treated with molgramostim inhalation solution
title_full_unstemmed Long-term outcomes in five patients with autoimmune pulmonary alveolar proteinosis treated with molgramostim inhalation solution
title_short Long-term outcomes in five patients with autoimmune pulmonary alveolar proteinosis treated with molgramostim inhalation solution
title_sort long term outcomes in five patients with autoimmune pulmonary alveolar proteinosis treated with molgramostim inhalation solution
url http://openres.ersjournals.com/content/11/1/00567-2024.full
work_keys_str_mv AT celiamontano longtermoutcomesinfivepatientswithautoimmunepulmonaryalveolarproteinosistreatedwithmolgramostiminhalationsolution
AT elisabethbendstrup longtermoutcomesinfivepatientswithautoimmunepulmonaryalveolarproteinosistreatedwithmolgramostiminhalationsolution
AT idarønnovjessen longtermoutcomesinfivepatientswithautoimmunepulmonaryalveolarproteinosistreatedwithmolgramostiminhalationsolution
AT sarasalgado longtermoutcomesinfivepatientswithautoimmunepulmonaryalveolarproteinosistreatedwithmolgramostiminhalationsolution
AT georgsterniste longtermoutcomesinfivepatientswithautoimmunepulmonaryalveolarproteinosistreatedwithmolgramostiminhalationsolution
AT arschangvalipour longtermoutcomesinfivepatientswithautoimmunepulmonaryalveolarproteinosistreatedwithmolgramostiminhalationsolution
AT marcelveltkamp longtermoutcomesinfivepatientswithautoimmunepulmonaryalveolarproteinosistreatedwithmolgramostiminhalationsolution
AT mariamolinamolina longtermoutcomesinfivepatientswithautoimmunepulmonaryalveolarproteinosistreatedwithmolgramostiminhalationsolution